Search (required) Sort by (required) RelevanceDate 1 result, showing 1 to 1 Aspen Global Incorporated - proposed acquisition of pharmaceutical product portfolio from GlaxoSmithKline Type Informal merger review Status Completed Outcome Not opposed Allowed to stand Date 2012 November 2012 07 November 2012
Aspen Global Incorporated - proposed acquisition of pharmaceutical product portfolio from GlaxoSmithKline